Company Profile

  • TOP  >  
  • Company Profile

Company ProfileAbout US

Business 1.Contract manufacturing of testing samples and intermediates, etc., for pharmaceutical research and development
2.Contract analysis of pharmaceuticals and development of quantitative and/or qualitative analytical methods for pharmaceuticals.
3.Contract early-stage drug discovery from target validation to validated hits acquisition using HTS and related technologies
4.Contract consulting on assessment and application of drug discovery related technologies
5.Contract clinical trial operation and related services
6.All activities attendant to the aforementioned
Paid-in capital \50 million

【Head Office】
1-16-13 Kitakasai, Edogawa-ku, Tokyo 134-8630
Phone: +81-03-5696-8301 (main)MAP

【Branch Office】
1-2-58, Hiromachi, Shinagawa-ku, Tokyo 140-8710 MAP


October 2006 DAIICHI SANKYO RD ASSOCIE CO., LTD. established
April 2007 Absorption-type merger of Science and Technology Research Center and Chem-Tech Lab of the Sankyo Group and Kanto Daiichi Service of the Daiichi Pharmaceutical Group Partial transfer of R&D services from the Daiichi Sankyo Group
October 2011 Name changed to DAIICHI SANKYO RD NOVARE Partial transfer of R&D service functions from Daiichi Sankyo, and business expansion

Contact UsContacts

Please refer to "Handling of personal information on this website" and "Terms and Conditions" before you make an inquiry.

  • ・Depending on the nature of your inquiry, it may take some time to reply or we may answer your inquiries by e-mail.
  • ・Please refrain from disclosing our answers to a person other than the intended recipient, by diverting or reusing them, whether wholly or partially, without our prior permission.
  • ・You can access the "Inquiry Form" 24 hours a day, 7 days a week. However, the hours we are available for inquiries are between 9 a.m. and 5 p.m. on weekdays (Japan time).
  • ・Please note that we will not be able to answer any inquiries related to diseases or medical treatments.
  • ・Daiichi Sankyo RD Novare reserves the right not to reply to unsolicited sales or advertising-related inquiries.

[ Please directly contact us by e-mail using the contact information below. ]